Stem cell therapies: a new era in the treatment of multiple sclerosis

This review focuses on the development and therapeutic applications of mesenchymal stem cell-derived neural progenitors (MSC-NPs) in MS treatment. It covers the transition from preclinical to clinical phases and discusses the potential of intrathecally administered autologous MSC-NPs in treating progressive MS.